Literature DB >> 32589359

The use of MitraClip to prevent posttranscatheter aortic valve replacement left ventricular "suicide".

Michael F Bode1, Andaleeb A Ahmed2, Suzanne J Baron1, Sherif B Labib1, Gautam Gadey1.   

Abstract

Patients with concomitant severe aortic stenosis (AS) and left ventricular outflow tract (LVOT) obstruction undergoing transcatheter aortic valve replacement (TAVR) are at risk for hemodynamic collapse due to a sudden decrease in afterload causing worsening LVOT obstruction. We present a case of an 88-year-old female with symptomatic, severe AS, and LVOT obstruction with systolic anterior motion (SAM) of the mitral leaflet in whom alcohol septal ablation was contraindicated secondary to a chronic total occlusion of the right coronary artery that filled retrograde via septal collaterals. MitraClip at the time of TAVR was successfully performed to treat SAM with subsequent stabilization of LVOT gradients despite treatment of the patient's AS. This novel approach may represent a feasible option to prevent hemodynamic complications after TAVR in patients with significant LVOT obstruction secondary to SAM and AS.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  MitraClip; aortic stenosis; left ventricular outflow tract obstruction; transcatheter aortic valve replacement

Year:  2020        PMID: 32589359     DOI: 10.1002/ccd.29100

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Haemodynamic collapse immediately after transcatheter aortic valve implantation due to dynamic intraventricular gradient: a case report and review of the literature.

Authors:  Nana Endo; Hisao Otsuki; Satoru Domoto; Junichi Yamaguchi
Journal:  Eur Heart J Case Rep       Date:  2021-01-12

2.  A Word of Caution Before Treating Aortic Stenosis in Patients With Concomitant LVOT Obstruction.

Authors:  Itsik Ben-Dor; Toby Rogers; Giorgio A Medranda; Diego Medvedofsky; Gaby Weissman; Brian C Case; Lowell F Satler; Ron Waksman
Journal:  JACC Case Rep       Date:  2022-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.